Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07442357
NA

The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial

Sponsor: Rigshospitalet, Denmark

View on ClinicalTrials.gov

Summary

The study is a prospective, crossover, cluster randomized trial in patients undergoing transcatheter aortic valve implantation (TAVI). The study tests whether cephalosporin plus beta-lactam antibiotic with spectrum for Enterococcus faecalis as per procedural prophylaxis is superior to cephalosporin alone in reducing the composite outcome of bacteremia or death at 6 months post-TAVI.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1986

Start Date

2026-06-01

Completion Date

2029-06-01

Last Updated

2026-03-02

Healthy Volunteers

No

Interventions

DRUG

Beta-lactam antibiotic with spectrum for Enterococcus faecalis

Beta-lactam antibiotic with spectrum for Enterococcus faecalis (e.g. ampicillin 2g) add-on in combination with cephalosporin as per-procedural prophylaxis in TAVI

DRUG

Cephalosporin

Cephalosporin treatment

Locations (1)

Copenhagen University Hospital, Rigshospitalet

Copenhagen, Denmark